Evidence map›Paper›PMID 18165707›Full record

ArticleThe Korean journal of parasitology2007

Protective effect of lectin from Synadenium carinatum on Leishmania amazonensis infection in BALB/c mice.

Sandra R Afonso-Cardoso, Flavio H Rodrigues, Marcio A B Gomes, Adriano G Silva, Ademir Rocha, Aparecida H B Guimaraes, Ignes Candeloro, Silvio Favoreto, Marcelo S Ferreira, Maria A de Souza

Open access · bronzeAbstract read
In one paragraph

Article in The Korean journal of parasitology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Ovicidal and toxicological effect of hydroalcoholic extracts ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Article
  6. Article
  7. Review
  8. Lectins fromFrontiers in cellular and infection microbiology · 2016
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sandra R Afonso-CardosoLaboratorio de Biologia Molecular, Instituto de Ciencias Biomedicas, Universidade Federal de Uberlandia, MG, Brazil.
Flavio H Rodrigues
Marcio A B Gomes
Adriano G Silva
Ademir Rocha
Aparecida H B Guimaraes
Ignes Candeloro
Silvio Favoreto
Marcelo S Ferreira
Maria A de Souza
Northwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protective effect of the Synadenium carinatum latex lectin (ScLL), and the possibility of using it as an adjuvant in murine model of vaccination against American cutaneous leishmaniasis, were evaluated. BALB/c mice were immunized with the lectin ScLL (10, 50, 100 microgram/animal) separately or in association with the soluble Leishmania amazonensis antigen (SLA). After a challenge infection with 10(6) promastigotes, the injury progression was monitored weekly by measuring the footpad swelling for 10 weeks. ScLL appeared to be capable of conferring partial protection to the animals, being most evident when ScLL was used in concentrations of 50 and 100 microgram/animal. Also the parasite load in the interior of macrophages showed significant reduction (61.7%) when compared to the control group. With regard to the cellular response, ScLL 50 and 100 microgram/animal stimulated the delayed-type hypersensitivity (DTH) reaction significantly (P < 0.05) higher than SLA or SLA plus ScLL 10 weeks after the challenge infection. The detection of high levels of IgG2a and the expression of mRNA cytokines, such as IFN-gamma, IL-12, and TNF-alpha (Th1 profiles), corroborated the protective role of this lectin against cutaneous leishmaniasis. This is the first report of the ScLL effect on leishmaniasis and shows a promising role for ScLL to be explored in other experimental models for treatment of leishmaniasis.

Indexed as

Adjuvants, ImmunologicAnimalsAntibodies, ProtozoanAntibody FormationAntigens, ProtozoanCytokinesEuphorbiaceaeHypersensitivity, DelayedImmunizationImmunoglobulin GLatexLeishmaniaLeishmaniasis, CutaneousMiceMice, Inbred BALB CNitric Oxide Synthase Type IIAdjuvants, ImmunologicAntibodies, ProtozoanAntigens, ProtozoanCytokinesImmunoglobulin GLatexNitric Oxide Synthase Type IINos2 protein, mousePlant LectinsProtozoan Vaccines

Identifiers

PMID18165707
PMCPMC2532627
OpenAlexW1998113368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.